跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Secunda - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Secunda
Approved
STANDARD
Secunda
Brawn Laboratories Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e487808a99c273fb
Company
Brawn Laboratories Limited
Type
Standard
Approval Details
Approval Id
e487808a99c273fb
Drug Approval Philippines Name
Secunda
Product Name
Secunda
Registration Number
DRP-4164-23
Brand Name
Secunda
Generic Name
Cefuroxime (As Axetil)
Dosage Form
Film-Coated Tablet
Dosage Strength
500 mg
Manufacturer
Brawn Laboratories Limited
Importer
Ambica International Corporation
Distributor
Ambicare Pharmaceuticals, Inc.
Issuance Date
25 May 2022
Expiry Date
27 December 2027
Pharmacologic Category
Antibacterial (Cephalosporin)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e487808a99c273fb
Type
Standard
Back to Philippines FDA Approvals